Literature DB >> 141966

Down's syndrome: an atheroma-free model?

J C Murdoch, J C Rodger, S S Rao, C D Fletcher, M G Dunnigan.   

Abstract

Postmortem examination of five institutionalised patients with Down's syndrome (DS) aged 40-66 years showed a complete absence of atheroma, while a similar number of mental defectives with DS were found to have mild or severe atheroma. Previous investigation of risk factors for atheroma in 70 patients with DS and 70 age-and sex-matched mental defectives living in the same institution showed significantly lower systolic and diastolic blood pressures in the DS group, with the exception of systolic pressure in men under 40. Fasting serum cholesterol and triglyceride concentrations were similar in the two groups, but triglyceride concentrations were significantly lower than in normal people without a history of vascular disease. These unexplained observations may be relevant in further studies of the pathogenesis of atheroma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 141966      PMCID: PMC1631400          DOI: 10.1136/bmj.2.6081.226

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  The electrocardiogram in population studies. A classification system.

Authors:  H BLACKBURN; A KEYS; E SIMONSON; P RAUTAHARJU; S PUNSAR
Journal:  Circulation       Date:  1960-06       Impact factor: 29.690

2.  An automated method for the direct determination of total serum cholesterol.

Authors:  W Annan; D M Isherwood
Journal:  J Med Lab Technol       Date:  1969-07
  2 in total
  55 in total

Review 1.  An overview and update regarding medical problems in Down syndrome.

Authors:  V Grech
Journal:  Indian J Pediatr       Date:  2001-09       Impact factor: 1.967

2.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 3.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

4.  Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain.

Authors:  J Motte; R S Williams
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Survival and morbidity outcomes for very low birth weight infants with Down syndrome.

Authors:  Nansi S Boghossian; Nellie I Hansen; Edward F Bell; Barbara J Stoll; Jeffrey C Murray; Abbot R Laptook; Seetha Shankaran; Michele C Walsh; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

6.  The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease.

Authors:  J B Ubbink; W J Vermaak; J M Bennett; P J Becker; D A van Staden; S Bissbort
Journal:  Klin Wochenschr       Date:  1991-08-16

7.  Body Composition and BMI Growth Charts in Children With Down Syndrome.

Authors:  Jacquelyn A Hatch-Stein; Babette S Zemel; Divya Prasad; Heidi J Kalkwarf; Mary Pipan; Sheela N Magge; Andrea Kelly
Journal:  Pediatrics       Date:  2016-09-14       Impact factor: 7.124

8.  Down syndrome and microRNAs.

Authors:  Aldina Brás; António S Rodrigues; Bruno Gomes; José Rueff
Journal:  Biomed Rep       Date:  2017-11-17

9.  Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.

Authors:  Alex M Helman; Morgan Siever; Katie L McCarty; Ira T Lott; Eric Doran; Erin L Abner; Frederick A Schmitt; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 10.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.